EUVIMEDEUVIMED entdecken
Crossref

10-year experience of 4% formalin endoscopic instillation for the treatment of chronic radiation proctopathy

A. Vella Baldacchino, K. Mushtaq, P. Boger, P. Patel, I. Rahman

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S479

DOI: 10.1055/s-0044-1783918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von A. Vella Baldacchino und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Chronic rectal proctopathy (CRP) complicates pelvic radiotherapy in 2-20% of cases, and can result in significant morbidity, with rectal bleeding and iron deficiency anaemia. Topical application of formalin can induce coagulative necrosis, and endoscopic instillation of formalin for the treatment of patients with CRP has been described. However, the evidence for formalin instillation has so far been limited to small case series with heterogenous protocols of application. The aim of this study was to assess the efficacy and safety of endoscopic formalin instillation for CRP in a large tertiary centre.

Methods

A prospectively collected database for consecutive patients with CRP referred between September 2013 to September 2023 for treatment with formalin instillation was analysed. At each session patients were treated with endoscopic rectal instillation of 30-50mls of a 4% formalin solution with 0.05mls of indigo carmine, until adequate coverage of the partially deflated rectum was achieved. After 2 minutes (or until tolerated), the formalin was aspirated and the rectum irrigated until no more dyed formalin was visible. Patient symptoms were scored using the subjective, objective management analysis (SOMA) scale, and the endoscopic severity of CRP was graded by the Zinicola score. These measures were taken pre-treatment and prior to any subsequently planned treatments if clinically warranted, typically at 6-week intervals up to a maximum of 3 sessions.

Results

51 patients (49 male) were referred for treatment. The mean age was 72 years. Mean duration of symptoms was 7.8 (+/- 3) months and the interval between radiotherapy and onset of symptoms was 11 (+/- 4) months. A median of 2 sessions were required (range 1-3). Post-treatment protocol SOMA score reduction was 8 to 1 (P=0.02) and mean Zinicola score reduction was from 4 to 2 (P=0.04). The only complication recorded was one case of an anaphylactoid reaction with facial flushing, which resolved with observation Conclusions This is one of the largest observational studies of endoscopic formalin instillation for CRP, which demonstrates that a modified technique enables effective, safe and cost-efficient treatment for radiation proctopathy. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Baldacchino, A. V., Mushtaq, K., Boger, P., Patel, P., & Rahman, I. (2024). 10-year experience of 4% formalin endoscopic instillation for the treatment of chronic radiation proctopathy. Endoscopy, 56(S 02 S 02), S479. https://doi.org/10.1055/s-0044-1783918

Vancouver

Baldacchino AV, Mushtaq K, Boger P, Patel P, Rahman I. 10-year experience of 4% formalin endoscopic instillation for the treatment of chronic radiation proctopathy. Endoscopy. 2024;56(S 02 S 02):S479. doi:10.1055/s-0044-1783918

BibTeX
@article{Baldacchino2024,
  author = {Baldacchino, A. Vella and Mushtaq, K. and Boger, P. and Patel, P. and Rahman, I.},
  title = {10-year experience of 4% formalin endoscopic instillation for the treatment of chronic radiation proctopathy},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S479},
  doi = {10.1055/s-0044-1783918}
}
Kostenlos starten →